Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology - 1 May 2001

Alsner J, Sørensen S B, Overgaard J

Abstract excerpt

BACKGROUND AND METHODS: TP53 gene-mutation and expression of p53 have been described to influence the radiosensitivity of tumour cells from head and neck carcinomas. The present study was performed to evaluate whether TP53 mutation may influence the clinical outcome of head and neck cancer patien...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Squamous Cell
Share to Chi-Square Distribution
Share to Head and Neck Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Laryngeal Neoplasms

Share to Mouth Neoplasms

Share to Multivariate Analysis

Share to Proportional Hazards Models

Share to Survival Analysis

Source

Identifiers

PMID: 11325447
DOI: 10.1016/s0167-8140(01)00301-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026. Prepared record publication-11325447-2026-08-31.1. Manifest publication-graph-cohort-2026-08-31.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 31 Aug 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck.PMID 11325447Read ↗

p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma.Semantic proximity Read ↗

TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response.Semantic proximity Read ↗

High-risk TP53 mutations predict poor primary treatment response of patients with head and neck squamous cell carcinoma.Semantic proximity Read ↗

TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selectionSemantic proximity Read ↗

p53 in head and neck cancer: Functional consequences and environmental implications of TP53mutationsSemantic proximity Read ↗

The possible role of TP53 mutation status in the treatment of squamous cell carcinomas of the head and neck (HNSCC) with radiotherapy with different overall treatment times.Semantic proximity Read ↗

TP53 mutations in head and neck cancer.Semantic proximity Read ↗

Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patients.Semantic proximity Read ↗

Computational analysis of TP53 mutational landscape unveils key prognostic signatures and distinct pathobiological pathways in head and neck squamous cell cancer.Semantic proximity Read ↗

TP53 and head and neck neoplasms.Semantic proximity Read ↗

Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival study.Semantic proximity Read ↗

Patterns of p53 gene mutations in head and neck cancer: full-length gene sequencing and results of primary radiotherapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.